URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
D001342:Autonomic Nervous System Diseases; D002746:Chlorpromazine; D004358:Drug Therapy; D005116:Extrapyramidal Tracts; D005441:Fluids and Secretions; D005767:Gastrointestinal Diseases; D006801:Humans; D006897:Hydroxyindoleacetic Acid; D007022:Hypotension; D007210:Indoleacetic Acids; D008333:Mandelic Acids; D008660:Metabolism; D009069:Movement Disorders; D010600:Pharmacology; D010636:Phenols; D012110:Reserpine; D012131:Respiratory Insufficiency; D012559:Schizophrenia; D014116:Toxicology; D014556:Urine
D007210:Indoleacetic Acids; D008333:Mandelic Acids; D010636:Phenols; D006897:Hydroxyindoleacetic Acid; C030737:indoleacetic acid; D012110:Reserpine; C037938:mandelic acid; D002746:Chlorpromazine
AUTONOMIC DYSFUNCTION; CHLORPROMAZINE; DRUG THERAPY; EXCRETION; EXTRAPYRAMIDAL TRACTS; GASTROINTESTINAL DISEASES; HYDROXYINDOLEACETIC ACID; HYPOTENSION; INDOLEACETIC ACID; MANDELIC ACID; METABOLISM; MOVEMENT DISORDERS; PHARMACOLOGY; PHENOLS; RESERPINE; RESPIRATORY INSUFFICIENCY; SCHIZOPHRENIA; TOXICOLOGIC REPORT; URINE